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The effect of 1 mM and 5 mM dichloroacetate on the catabolism of branched-chain amino acids in isolated 
rat hindlimbs was investigated in perfusions with 0.5 mM I-Y-labeled L-leucine or L-valine. The results 
demonstrate an increasing effect of dichloroacetate on the flux through skeletal muscle branched-chain 2- 
0x0 acid dehydrogenase. A minor effect was observed with the high dichloroacetate concentration. Evidence 
is presented that this was essentially due to diminished pyruvate supply. 
Dichloroacetate Branched-chain amino acid Pyruvate Perfused rat hindlimb 
1. INTRODUCTION 2. EXPERIMENTAL 
DCA has been shown to increase the catabolism 
of BCAA in the perfused rat heart [l]. This seems 
to be primarily due to the inhibitory effect of the 
compound on BCOA-DH kinase [2] As in the 
heart, BCOA-DH in skeletal muscle is regulated by 
a phosphorylation-dephosphorylation mechanism 
[3-51. However, in recirculating perfusion of rat 
hindquarters, DCA increased BCAA release [6]. In 
cultured rat skeletal muscle cells, 14C02 produc- 
tion from L-[l-14C]leucine was reduced on incuba- 
tion with DCA [7]. Similar decreasing effects on 
the catabolism of leucine and valine were observed 
with incubated rat hemidiaphragms [8,9]. This 
communication reports on an increasing but dif- 
ferential effect of 1 mM, and 5 mM DCA on 
BCAA catabolism in isolated rat hindlimbs per- 
fused under steady-state conditions. 
Abbreviations: BCAA, branched-chain amino acid; 
BCOA, branched-chain 2-0~0 acid; BCOA-DH, 
branched-chain 2-0~0 acid dehydrogenase (EC 1.2.4.4); 
DCA, dichloroacetate 
Non-recirculating perfusion of rat hindlimbs 
with a medium containing 0.5 mM l-‘4C-labeled 
BCAA (0.4-0.9 MBq/mmol) or 0.15 mM 
[l-‘4C]pyruvate (1.3-2.6 MBq/mmol) as the sole 
substrate was performed as in [lo]. In the effluent, 
the label incorporated into 14C02 and 
[ l-14C]BCOA was determined as in [lo]. BCOA 
concentrations were measured according to [I l] 
and were used to calculate the specific radioactivity 
and the release rate of BCOA as detailed in [lo]. 
Amino acids were determined on an automatic 
amino acid analyzer, and lactate was measured as 
in [12]. 
The label incorporated into 14C02 and 
[1-‘4C]BCOA was used to calculate the respective 
release rates on the basis of the specific iadioactivi- 
ty of the precursor in the influent. To take into ac- 
count the intracellular dilution of label [5,10], the 
oxidation rates of BCOA were estimated from the 
14C02 production on the basis of the specific 
radioactivity of l-‘4C-labeled BCOA in the ef- 
fluent. The transamination rates were calculated 
from BCOA release and oxidation rates. 
The sources for the radioactive and unlabeled 
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material were as in [lo]. Results are means rt SD 
from determinations during the metabolic and 
isotopic steady state of perfusion (n = 3-8); Stu- 
dent’s paired t-test was used. 
3. RESULTS 
In perfusions with I-‘4C-labeled leucine and 
valine (table l), addition of 5 mM DCA decreased 
the release of the corresponding BCOA by about 
50 and SO~ff (P<O.OOl), respectively. The trans- 
amination rate of leucine remained unchanged and 
the transamination of valine was slightly decreased 
(P<O.O5). After termination of 5 mM DCA infu- 
sion, the BCOA release increased and returned to 
the control value (fig.1, upper). However, the 
14C02 release was transiently enhanced and then 
gradually declined. In experiments with 1 mM 
DCA we examined whether this was due to the 
dilution of DCA during the wash-out period. The 
increase of BCOA oxidation was more distinct 
with the low DCA concentration (table 1). No ad- 
ditional increase of 14C02 production occurred 
after termination of 1 mM DCA infusion. 
The effects of I mM and 5 mM DCA were 
directly compared in experiments as shown in fig. 1 
(lower). Either concentration of DCA decreased 
the BCOA release to a similar extent (cf. table 1). 
The portion of the transamination products of 
leucine and valine undergoing decarboxylation was 
increased from 40 & 6% and and 14 k 5%, 
respectively, to about 70010 by either DCA concen- 
tration (P<O.O05). However, as compared to 1 
mM, 5 mM DCA decreased the oxidation rate in 
perfusions with leucine (PcO.005) and valine 
(FcO.05) by about 40%. 
It has been argued 191 that decreasing effects of 
DCA on skeletal muscle BCAA catabolism might 
be a result of increasing effects on pyruvate 
catabolism. In fact, in perfusions with leucine, ad- 
dition of 1 mM and 5 mM DCA decreased the 
release of lactate (245 + 35 nmol/min per g mus- 
cle) in a concentration-dependent manner by 13 it 
6% (F<0.05) and by 36 + 3% (P<O.OOl), respec- 
tively. Release rates of amino acids were not re- 
duced significantly, with the exception of alanine 
production (45 rfr 11 nmob’min per g muscle), 
which was decreased by 27 + 3% and by 36 f 3glo 
Table 1 
Differential effect of dichloroacetate on the catabolism of branched-chain amino acids in 
isolated perfused rat hindlimbs 
Amino acid 
added 
(0.5 mM) 
IDCAl 
(mM) 
2-0~0 acid 
release 
2-0~0 acid Amino acid 
oxidation transamination 
(nmol/min per g 
muscle) 
0 13.8 1?1 1.2 10 + 3 23 I!Z 4 
L-Leucine 1 7.6 f 0.6 28 + 8 36 z!z 8 
5 7.3 zk 1.2 16 f 4 22 -t 5 
0 11.8 t 0.9 2+1 14 f 3 
L-Valine 1 4.3 -t 1.1 11 + 2 15 -+ 3 
5 2.4 -+ 1.2 8t3 9+_3 
Results are means + SD from determinations before and after addition of DCA. Effects of 
1 mM and 5 mM DCA were measured in at least 4 independent experiments with 1-14C- 
labeled BCAA (for experimental protocol see fig. 1, upper). 2-0~0 acid refers to the cor- 
responding BCOA. The 14C02 release (6.8 k 1.5, 12.9 f 1.2 and 9.2 f 1.8 nmob’min per 
g muscle in perfusions with Ieucine and 1.1 & 0.2, 5.0 $: 0.7 and 3.2 k 0.5 nmol/m~n per 
g muscle in perfusions with valine at 0, 1 and 5 mM DCA, respectively) was corrected for 
the intracellular dilution of label to yield BCOA oxidation rates. For further experimental 
details see section 2 
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1mM OCA [ 5mM OCA 
+ 
Time of Derfuslon Imln) 
Fig. 1. Effect of dichloroacetate on the 14C02 release and 
2-0~0 1-r4C-labeled acid production from i-r4C-labeled 
branched-chain amino acids in isolated perfused rat 
hindlimbs. Non-recirculating perfusion was carried out 
with 0.5 mM BCAA as the sole substrate. DCA was add- 
ed to the influent at the time and concentration as in- 
dicated. Representative xperiments are shown. Similar 
effects were observed with either amino acid (cf. table 
1). For further details see sections 2 and 3. 
(P<O.O5), respectively. These findings are in ac- 
cordance with the concentration-dependent effect 
of DCA on 14C02 release from [l-14C]pyruvate 
(fig.2, cf. 171). 
Therefore, the effect of improved pyruvate 
supply was examined in perfusions with leucine 
and in the presence of 5 mM DCA (fig.3). After 
addition of 0.5 mM pyruvate, the BCOA release 
was increased from 8 + 2 to 18 f 6 ~o~/rnin per 
g muscle (P<O.O5). The oxidation rate was 
enhanced from 15 f 4 to 17 + 3 nmol/min per g 
muscle (PcO.05). Thus the transamination rate 
was increased by 52 -+ 5% (P<O.O5). 
Oichfor~cetate cont. (mM1 
Fig.2. Effect of dichloroacetate on the ‘%ZOZ release in 
non-recirculating perfusion of rat hindlimbs with 0.15 
mM [l-‘4C]pyruvate. Results are means f SD for at 
least 3 independent experiments (for experimental pro- 
tocol cf. fig.1, upper). Effects of DCA are expressed as 
the multiplier of the value during the preceding DCA- 
free perfusion. The effect of DCA was significant 
(P<O.OOS) at concentrations>O.5 mM. The effect of 5 
mM vs 1 mM DCA was significant at PcO.01 as deter- 
mined by Student’s non-paired t-test. For further details 
see section 2. 
Ttme of perfusIon tmtnl 
Fig.3. Effect of pyruvate on the 14COz release and 2-0~0 
l-i4C-labeled acid production from 0.5 mM L- 
[I-‘4C]leucine in isolated perfused rat hindlimbs in the 
presence of 5 mM dichloroacetate. Sodium pyruvate was 
added to the influent at the time and concentration as in- 
dicated. For further details see sections 2 and 3. 
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4. DISCUSSION 
The present experiments demonstrate an increas- 
ing effect of 1 mM and 5 mM DCA on the decar- 
boxylation of leucine and valine in isolated per- 
fused rat hindlimbs. It is rather unlikely that the 
minor effect of 5 mM DCA was due to an inhibi- 
tion of the BCOA-DH. This should increase 
BCOA release, decrease the ratio of oxidation to 
transamination, and would not explain the dif- 
ferences in the transamination rates. An inhibitory 
effect on BCAA aminotransferase has been ex- 
cluded [9]. A reasonable explanation is provided 
by the hypothesis [9] that in skeletal muscle, 
BCAA transamination might be coupled to alanine 
formation by the BCAA aminotransferase (EC 
2.6.1.42) and the alanine aminotransferase (EC 
2.6.1.2) reaction. Thus the transamination of 
BCAA could be, at least in part, dependent on 
pyruvate availability. 
Taken together, the concentration-dependent ef-
fects of DCA and BCAA transamination rates, the 
lactate and alanine production, the i4COz release 
from [l-‘4C]pyruvate, and the results of pyruvate 
supplementation experiments suggest that the 
minor effect of 5 mM DCA on BCOA oxidation 
was essentially due to a diminished availability of 
pyruvate, which led to an impaired rate of trans- 
amination and to a decreased substrate supply for 
the BCOA-DH . 
With respect to the mechanism it is not likely 
that DCA greatly affected BCOA-DH flux by 
changes in tissue BCOA concentrations. In 
hindlimb perfusions with 0.5 mM leucine, the in- 
tracellular BCOA remained low [13] and the con- 
centration seems to be far below an apparent Ki for 
the BCOA-DH kinase [2,14]. Furthermore, as 
evidenced by the oxidation/transamination ratios 
in perfusions with leucine or valine, the DCA- 
induced degree of increase in BCOA-DH flux was 
apparently independent from the transamination, 
i.e. BCOA production rate. 
The evidence presented suggests that DCA 
directly affected the activity state of the BCOA- 
DH. In the perfused rat heart, the DCA induced- 
increase of BCAA decarboxylation is presumably 
due to an inhibition of the BCOA-DH kinase [1,2] 
with subsequent dephosphorylation and activation 
of the BCOA-DH. Whether a similar mechanism 
also applied to the present experiments, is now 
under investigation. 
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